Skip to main content
PMC home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1980 Mar;39(3):657–662.

Dysfunction of natural killer cells in multiple sclerosis: a possible pathogenetic factor.

M Benczur, G G Petrányl, G Pálffy, M Varga, M Tálas, B Kotsy, I Földes, S R Hollán
PMCID: PMC1538133  PMID: 6155232

Abstract

Natural killer (NK) cell activity, antibody-dependent cytotoxicity (ADCC) and the effect of interferon on NK activity was investigated in multiple sclerosis (MS) patients. NK activity measured against K-562 tumour cell line was found to be significantly low in MS patients, and this was most pronounced in the group of male patients with definitive disease. The response of NK cells to interferon proved to be impaired and almost no activation could be demonstrated in response to polyinosinic-polycytidylic acid (poly I:C). Preliminary data obtained by the determination of interferon production in several definitive MS cases reflect a defect in the interferon producing capacity of lymphocytes. The possible involvement of impaired NK cell function in the aetiopathogenesis of MS is discussed.

Full text

PDF
659

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ammitzboll T., Clausen J. Measles antibody in serum of multiple sclerosis patients, their children, siblings and parents. Acta Neurol Scand. 1972;48(1):47–56. doi: 10.1111/j.1600-0404.1972.tb07526.x. [DOI] [PubMed] [Google Scholar]
  2. Batchelor J. R., Compston A., McDonald W. I. The significance of the association between HLA and multiple sclerosis. Br Med Bull. 1978 Sep;34(3):279–284. doi: 10.1093/oxfordjournals.bmb.a071512. [DOI] [PubMed] [Google Scholar]
  3. Djeu J. Y., Heinbaugh J. A., Holden H. T., Herberman R. B. Augmentation of mouse natural killer cell activity by interferon and interferon inducers. J Immunol. 1979 Jan;122(1):175–181. [PubMed] [Google Scholar]
  4. Ebina T., Tsukamoto T., Suzuki H., Takase S., Itahara K., Ishida N. Measles virus in jejunum of patients with multiple sclerosis. Lancet. 1979 Jan;1(8107):99–99. doi: 10.1016/s0140-6736(79)90082-5. [DOI] [PubMed] [Google Scholar]
  5. Field A. K., Tytell A. A., Lampson G. P., Hilleman M. R. Inducers of interferon and host resistance. II. Multistranded synthetic polynucleotide complexes. Proc Natl Acad Sci U S A. 1967 Sep;58(3):1004–1010. doi: 10.1073/pnas.58.3.1004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Gidlund M., Orn A., Wigzell H., Senik A., Gresser I. Enhanced NK cell activity in mice injected with interferon and interferon inducers. Nature. 1978 Jun 29;273(5665):759–761. doi: 10.1038/273759a0. [DOI] [PubMed] [Google Scholar]
  7. Gravell M., Hamilton R. S., Kiefer R. H., Madden D. L., Sever J. L., Tourtellotte W. W. PAM cell assay as a tests for multiple-sclerosis associated agent. Neurology. 1978 Oct;28(10):1050–1052. doi: 10.1212/wnl.28.10.1050. [DOI] [PubMed] [Google Scholar]
  8. Haller O., Hansson M., Kiessling R., Wigzell H. Role of non-conventional natural killer cells in resistance against syngeneic tumour cells in vivo. Nature. 1977 Dec 15;270(5638):609–611. doi: 10.1038/270609a0. [DOI] [PubMed] [Google Scholar]
  9. Herberman R. B., Holden H. T. Natural cell-mediated immunity. Adv Cancer Res. 1978;27:305–377. doi: 10.1016/s0065-230x(08)60936-7. [DOI] [PubMed] [Google Scholar]
  10. Herberman R. R., Ortaldo J. R., Bonnard G. D. Augmentation by interferon of human natural and antibody-dependent cell-mediated cytotoxicity. Nature. 1979 Jan 18;277(5693):221–223. doi: 10.1038/277221a0. [DOI] [PubMed] [Google Scholar]
  11. Jersild C., Ammitzboll T., Clausen J., Fog T. Association between HL-A antigens and measles antibody in multiple sclerosis. Lancet. 1973 Jan 20;1(7795):151–152. doi: 10.1016/s0140-6736(73)90224-9. [DOI] [PubMed] [Google Scholar]
  12. Lawrence D., Fish P. J., Kakkar V. V. Blood-flow in incompetent perforating veins. Lancet. 1977 Jan 15;1(8003):117–118. doi: 10.1016/s0140-6736(77)91705-6. [DOI] [PubMed] [Google Scholar]
  13. Lowitzsch K., Kuhnt U., Sakmann C., Maurer K., Hopf H. C., Schott D., Thäter K. Visual pattern evoked responses and blink reflexes in assessment of MS diagnosis. A clinical study of 135 multiple sclerosis/pathol. J Neurol. 1976 Jul 15;213(1):17–32. doi: 10.1007/BF00316336. [DOI] [PubMed] [Google Scholar]
  14. Lozzio C. B., Lozzio B. B. Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome. Blood. 1975 Mar;45(3):321–334. [PubMed] [Google Scholar]
  15. Macfarlan R. I., Burns W. H., White D. O. Two cytotoxic cells in peritoneal cavity of virus-infected mice: antibody-dependent macrophages and nonspecific killer cells. J Immunol. 1977 Nov;119(5):1569–1574. [PubMed] [Google Scholar]
  16. Mitchell D. N., Porterfield J. S., Micheletti R., Lange L. S., Goswami K. K., Taylor P., Jacobs J. P., Hockley D. J., Salsbury A. J. Isolation of an infectious agent from bone-marrows of patients with multiple sclerosis. Lancet. 1978 Aug 19;2(8086):387–391. doi: 10.1016/s0140-6736(78)91862-7. [DOI] [PubMed] [Google Scholar]
  17. Petrányi G. G., Benczur M., Onody C. E., Hollán S. R. Letter: HL-A 3,7 and lymphocyte cytotoxic activity. Lancet. 1974 Apr 20;1(7860):736–736. doi: 10.1016/s0140-6736(74)92943-2. [DOI] [PubMed] [Google Scholar]
  18. Santoli D., Koprowski H. Mechanisms of activation of human natural killer cells against tumor and virus-infected cells. Immunol Rev. 1979;44:125–163. doi: 10.1111/j.1600-065x.1979.tb00269.x. [DOI] [PubMed] [Google Scholar]
  19. Santoli D., Trinchieri G., Zmijewski C. M., Koprowski H. HLA-related control of spontaneous and antibody-dependent cell-mediated cytotoxic activity in humans. J Immunol. 1976 Sep;117(3):765–770. [PubMed] [Google Scholar]
  20. Trinchieri G., Santoli D. Anti-viral activity induced by culturing lymphocytes with tumor-derived or virus-transformed cells. Enhancement of human natural killer cell activity by interferon and antagonistic inhibition of susceptibility of target cells to lysis. J Exp Med. 1978 May 1;147(5):1314–1333. doi: 10.1084/jem.147.5.1314. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Trinchieri G., Santoli D., Dee R. R., Knowles B. B. Anti-viral activity induced by culturing lymphocytes with tumor-derived or virus-transformed cells. Identification of the anti-viral activity as interferon and characterization of the human effector lymphocyte subpopulation. J Exp Med. 1978 May 1;147(5):1299–1313. doi: 10.1084/jem.147.5.1299. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Welsh R. M., Jr, Zinkernagel R. M. Heterospecific cytotoxic cell activity induced during the first three days of acute lymphocytic choriomeningitis virus infection in mice. Nature. 1977 Aug 18;268(5621):646–648. doi: 10.1038/268646a0. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES